Browse by UCL people
Group by: Type | Date
Number of items: 6.
2017
Molyneaux, PL;
Cox, MJ;
Wells, AU;
Kim, HC;
Ji, W;
Cookson, WOC;
Moffatt, MF;
... Maher, TM; + view all
(2017)
Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis.
Respiratory Research
, 18
, Article 29. 10.1186/s12931-017-0511-3.
|
|
Rinciog, C;
Watkins, M;
Chang, S;
Maher, TM;
LeReun, C;
Esser, D;
Diamantopoulos, A;
(2017)
A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK.
Pharmacoeconomics
, 35
(4)
pp. 479-491.
10.1007/s40273-016-0480-2.
|
 |
2016
|
Evans, IC;
Barnes, JL;
Garner, IM;
Pearce, DR;
Maher, TM;
Shi-Wen, X;
Renzoni, EA;
... McAnulty, RJ; + view all
(2016)
Epigenetic Regulation of Cyclooxygenase-2 by methylation of c8orf4 in Pulmonary Fibrosis.
Clinical Science
, 130
(8)
pp. 575-586.
10.1042/CS20150697.
|
|
Mercer, PF;
Woodcock, HV;
Eley, JD;
Platé, M;
Sulikowski, MG;
Durrenberger, PF;
Franklin, L;
... Chambers, RC; + view all
(2016)
Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF.
Thorax
, 71
(8)
pp. 701-711.
10.1136/thoraxjnl-2015-207429.
|
|
2015
|
Holman, BF;
Cuplov, V;
Millner, L;
Hutton, BF;
Maher, TM;
Groves, AM;
Thielemans, K;
(2015)
Improved correction for the tissue fraction effect in lung PET/CT imaging.
Physics in Medicine and Biology
, 60
(18)
pp. 7387-7402.
10.1088/0031-9155/60/18/7387.
|
|
2013
|
Win, T;
Thomas, BA;
Lambrou, T;
Hutton, BF;
Screaton, NJ;
Porter, JC;
Maher, TM;
... Groves, AM; + view all
(2013)
Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients.
European Journal of Nuclear Medicine and Molecular Imaging
, 41
(2)
337- 342.
10.1007/s00259-013-2514-8.
|
 |
